Medical News

RSS

Common cholinesterase inhibitor eases behavioral symptoms like agitation, depression, and psychosis in patients

The so-called "memory drugs" used to treat Alzheimer's disease and other causes of dementia also ease or prevent a barrage of troublesome behaviors that affect the majority of patients, ultimately lightening the burden on caregivers, researchers have found. They report their results in the March issue of the American Journal of Psychiatry.

5 Apr 2004

Missed opportunities for addressing HIV testing remain unacceptably high

The researchers, led by Jeffrey Samet, MD, professor of medicine at BUSM and chief of General Internal Medicine at Boston Medical Center (BMC), performed a 10-year retrospective chart review of patients seen at an HIV intake clinic between January 1994 and June 2001 who: 1) tested positive for HIV during the 12 months prior to their presentation at the intake clinic and 2) had one or more encounters recorded in the medical record prior to their HIV positive status.

5 Apr 2004

Professor Michael Banner to head ESRC Genomics Research Forum

Professor Michael Banner will join the University from King's College London, to be Director of the ESRC Genomics Research Forum. Professor Banner is well known in science and public policy arenas. He is currently Chair of the Home Office Animal Procedures Committee, and formerly chaired the Department of Health's CJD Incidents Panel.

5 Apr 2004

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported today that it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's observations concerning the Good Manufacturing Practice (GMP) regulations.

5 Apr 2004

Michigan opens new center to treat exposure to Vermiculite, Taconite, Asbestos

In response to the United States Environmental Protection Agency's (EPA) identification of major sources of public asbestos exposure in Michigan, the Barbara Ann Karmanos Cancer Institute and the Center for Occupational and Environmental Medicine (COEM) affiliated with Wayne State University (WSU) have joined forces to establish The National Center for Vermiculite and Asbestos-Related Cancers.

5 Apr 2004

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

ProMetic Life Sciences Inc. has announced today that its joint venture with the American Red Cross, Pathogen Removal and Diagnostic Technology Inc. ("PRDT"), has confirmed that treatment of TSE spiked red blood cell concentrate with its Prion Reduction Device results in a significant decrease in associated infectivity.

5 Apr 2004

SkyePharma agreement with Medeus Pharma for marketing and distribution of DepoMorphine

SkyePharma PLC has announced that it has entered into a strategic marketing agreement with Medeus Pharma for the marketing and distribution of DepoMorphine(TM) in Europe. DepoMorphine(TM) is SkyePharma's novel sustained-release injectable formulation of morphine for relief of moderate-to-severe post-operative pain. DepoMorphine(TM) was filed in the US and Europe last year and approvals are anticipated to commence in the second half of 2004.

5 Apr 2004

BRITONS risk dying prematurely from cancer due to ignorance

An NOP survey, released today by Cancer Research UK's Race for Life, reveals that only three per cent of those surveyed know that people who are overweight are more likely to develop cancer than people of normal weight, while 70 per cent are aware of the link with heart disease.

5 Apr 2004

New MRI Liver Contrast Agent Primovist(TM) Approved in Sweden

Schering AG Group, Germany has announced that the Swedish health authority MPA has granted marketing approval for its innovative liver imaging product Primovist(TM) (gadoxetic acid disodium). Primovist(TM) is designed for the detection and characterization of liver lesions by magnetic resonance imaging (MRI) including liver tumors, metastases as well as other malignant and benign lesions.

5 Apr 2004

Online, web-based system for ordering total parenteral nutrition (TPN)

Researchers at the Johns Hopkins Children's Center have designed an online, Web-based system for ordering total parenteral nutrition (TPN) that identifies and pre-emptively eliminates potentially serious calculation errors.

5 Apr 2004

Sheepskin reduces the incidence of pressure ulcers by 58 per cent.

A major cause of patient pain and suffering and additional healthcare costs in hospitals and aged care facilities - pressure ulcers (bed sores)- can be more than halved by using a simple but effective bedding overlay product developed by CSIRO.

5 Apr 2004

Surgeons suggests that the development of osteoarthritis in the knee following an injury may be both predictable and preventable

A new theory of joint function presented in a symposium at the 71st annual meeting of the American Academy of Orthopaedic Surgeons suggests that the development of osteoarthritis in the knee following an injury may be both predictable and preventable.

5 Apr 2004

AMA advises physicians to order influenza vaccine

In order to ensure the availability of influenza vaccine for administration early this coming fall, the AMA recommends that physicians and providers begin to order supplies of influenza vaccine immediately. In 2003, large numbers of cases of influenza began to appear in October, and activity was widespread.

5 Apr 2004

Upcoming symposium to examine mercury exposure

The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.

5 Apr 2004

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad’ cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU’s mutual recognition procedure.

4 Apr 2004

Yohimbe Tree Bark Hold Promise for Revolutionizing Treatment of Anxiety Disorders

New findings at the UCLA Neuropsychiatric Institute demonstrate the potential of a substance found in yohimbe tree bark to accelerate recovery from anxiety disorders suffered by millions of Americans.

4 Apr 2004

Doctors Likelier to Delay Prescribing Antiretroviral Drugs for Women and Minority HIV Patients

A new UCLA study finds that doctors who follow guidelines recommending the delay of antiretroviral therapy for non-adherent HIV patients are likelier to put off that treatment for Latinos, women and poor patients than they do for others. In addition, doctors are slower to prescribe protease inhibitors for African American patients whether or not the physician follows the guidelines.

4 Apr 2004

Mathematicians Predict Patterns in Fingerprints

Patterns in nature can be seen every day, yet in many cases, little is understood about how and why they form. Now University of Arizona mathematicians have found a way to predict natural patterns, including fingerprints and the spirals seen in cacti.

4 Apr 2004

Study Looks at Risk Factors for Range-of-Motion Limitations In Young Males with Hemophilia

A paper in the April issue of Blood detailed research on the prevalence and risk factors joint range of motion (ROM) limitation among young males with hemophilia.

4 Apr 2004

Video consultations to ease stress on frail patients

Monash University's Department of Geriatric Medicine is pioneering a high-tech way of consulting with elderly patients so they do not have to leave their nursing home beds.

4 Apr 2004

Medical News

Common cholinesterase inhibitor eases behavioral symptoms like agitation, depression, and psychosis in patients

Missed opportunities for addressing HIV testing remain unacceptably high

Professor Michael Banner to head ESRC Genomics Research Forum

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Michigan opens new center to treat exposure to Vermiculite, Taconite, Asbestos

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

SkyePharma agreement with Medeus Pharma for marketing and distribution of DepoMorphine

BRITONS risk dying prematurely from cancer due to ignorance

New MRI Liver Contrast Agent Primovist(TM) Approved in Sweden

Online, web-based system for ordering total parenteral nutrition (TPN)

Sheepskin reduces the incidence of pressure ulcers by 58 per cent.

Surgeons suggests that the development of osteoarthritis in the knee following an injury may be both predictable and preventable

AMA advises physicians to order influenza vaccine

Upcoming symposium to examine mercury exposure

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Yohimbe Tree Bark Hold Promise for Revolutionizing Treatment of Anxiety Disorders

Doctors Likelier to Delay Prescribing Antiretroviral Drugs for Women and Minority HIV Patients

Mathematicians Predict Patterns in Fingerprints

Study Looks at Risk Factors for Range-of-Motion Limitations In Young Males with Hemophilia

Video consultations to ease stress on frail patients

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News